Folate and long-chain polyunsaturated fatty acids in psychiatric disease

Journal of Nutritional Biochemistry

Volumn 17, Issue 11, 2006, Pages 717-727

  Muskiet, Frits A J ^a   Kemperman, Ramses F J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autism; Depression; Epigenetics; Folate; Long chain polyunsaturated fatty acids; One carbon metabolism; Schizophrenia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; FISH OIL; FOLIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LONG CHAIN FATTY ACID; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ADAPTATION; AUTISM; BIPOLAR DISORDER; CARBON METABOLISM; CELL MEMBRANE; CLINICAL TRIAL; DEPRESSION; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZYGOTIC TWINS; DNA METHYLATION; FISH; FOOD INTAKE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC EPIGENESIS; HEREDITY; HOMOZYGOTE; HUMAN; HUNGER; IMMIGRANT; INCIDENCE; LIPID BRAIN LEVEL; LOW BIRTH WEIGHT; MALNUTRITION; MATERNAL NUTRITION; MEAT; MEMBRANE STRUCTURE; MENTAL DISEASE; MENTAL PATIENT; METABOLIC SYNDROME X; MONOZYGOTIC TWINS; NEURAL TUBE DEFECT; PREGNANCY COMPLICATION; PROMOTER REGION; PUERPERAL DEPRESSION; REVIEW; SCHIZOPHRENIA; SEASONAL VARIATION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANIMALS; BIRTH WEIGHT; EPIGENESIS, GENETIC; FATTY ACIDS, UNSATURATED; FOLIC ACID; HUMANS; MENTAL DISORDERS; PHOSPHOLIPIDS;

EID: 33749681965     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2006.02.001     Document Type: Review

References (121)

1. Brune M. Schizophrenia - an evolutionary enigma?. Neurosci Biobehav Rev 28 1 (2004) 41-53
2. Horrobin D.F. The madness of Adam and Eve. How schizophrenia shaped humanity (2001), Cox & Wyman Ltd Reading, Berkshire (UK)
3. Blaxill M.F. What's going on? The question of time trends in autism. Public Health Rep 119 6 (2004) 536-551
4. Wassink T.H., Brzustowicz L.M., Bartlett C.W., and Szatmari P. The search for autism disease genes. Ment Retard Dev Disabil Res Rev 10 4 (2004) 272-283
5. Cantor-Graae E., and Selten J.P. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 162 1 (2005) 12-24
6. Green M. Schizofrenie ontsluierd (2003), Nieuwezijds, The Netherlands
7. Gottesman I.I., and Hanson D.R. Human development: biological and genetic processes. Annu Rev Psychol 56 (2005) 263-286
8. Joseph J. Twin studies in psychiatry and psychology: science or pseudoscience?. Psychiatr Q 73 1 (2002) 71-82
9. Davis J.O., Phelps J.A., and Bracha H.S. Prenatal development of monozygotic twins and concordance for schizophrenia. Schizophr Bull 21 3 (1995) 357-366
10. Kato T., Iwamoto K., Kakiuchi C., Kuratomi G., and Okazaki Y. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol Psychiatry 10 7 (2005) 622-630
11. Gluckman P.D., and Pinal C.S. Regulation of fetal growth by the somatotrophic axis. J Nutr 133 5 Suppl 2 (2003) 1741S-1746S
12. Godfrey K.M., and Barker D.J. Fetal nutrition and adult disease. Am J Clin Nutr 71 5 Suppl (2000) 1344S-1352S
13. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A., et al. Developmental plasticity and human health. Nature 430 6998 (2004) 419-421
14. Wahlbeck K., Forsen T., Osmond C., Barker D.J., and Eriksson J.G. Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood. Arch Gen Psychiatry 58 1 (2001) 48-52
15. Indredavik M.S., Vik T., Heyerdahl S., Kulseng S., and Brubakk A.M. Psychiatric symptoms in low birth weight adolescents, assessed by screening questionnaires. Eur Child Adolesc Psychiatry 14 4 (2005) 226-236
16. Glasson E.J., Bower C., Petterson B., de Klerk N., Chaney G., and Hallmayer J.F. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 61 6 (2004) 618-627
17. Larsson H.J., Eaton W.W., Madsen K.M., Vestergaard M., Olesen A.V., Agerbo E., et al. Risk factors for autism: perinatal factors, parental psychiatric history, and socioeconomic status. Am J Epidemiol 161 10 (2005) 916-925
18. Cannon M., Jones P.B., and Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159 7 (2002) 1080-1092
19. Susser E., Neugebauer R., Hoek H.W., Brown A.S., Lin S., Labovitz D., et al. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry 53 1 (1996) 25-31
20. St Clair D., Xu M., Wang P., Yu Y., Fang Y., Zhang F., et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 294 5 (2005) 557-562
21. Marzullo G., and Fraser F.C. Similar rhythms of seasonal conceptions in neural tube defects and schizophrenia: a hypothesis of oxidant stress and the photoperiod. Birth Defects Res A Clin Mol Teratol 73 1 (2005) 1-5
22. Braekke K., and Staff A.C. Periconceptional use of folic acid supplements in Oslo. Acta Obstet Gynecol Scand 82 7 (2003) 620-627
23. Buescher P.A. A review of available data on the health of the Latino population in North Carolina. N C Med J 64 3 (2003) 97-105
24. Checa M.A., Peiro R., Pascual J., and Carreras R. Drug intake behaviour of immigrants during pregnancy. Eur J Obstet Gynecol Reprod Biol 121 1 (2005) 38-45
25. Ray J.G., Vermeulen M.J., Meier C., Cole D.E., and Wyatt P.R. Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ 171 4 (2004) 343-345
26. Muntjewerff J.W., Kahn R.S., Blom H.J., and den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry 11 2 (2006) 143-149
27. Lewis S.J., Zammit S., Gunnell D., and Smith G.D. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am J Med Genet B Neuropsychiatr Genet 135 1 (2005) 2-4
28. Moretti P., Sahoo T., Hyland K., Bottiglieri T., Peters S., del Gaudio D., et al. Cerebral folate deficiency with developmental delay, autism, and response to folinic acid. Neurology 64 6 (2005) 1088-1090
29. Smits L., Pedersen C., Mortensen P., and van Os J. Association between short birth intervals and schizophrenia in the offspring. Schizophr Res 70 1 (2004) 49-56
30. Wahlbeck K., Osmond C., Forsen T., Barker D.J., and Eriksson J.G. Associations between childhood living circumstances and schizophrenia: a population-based cohort study. Acta Psychiatr Scand 104 5 (2001) 356-360
31. Hopper K., and Wanderling J. Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophr Bull 26 4 (2000) 835-846
32. Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids 69 6 (2003) 477-485
33. Applebaum J., Shimon H., Sela B.A., Belmaker R.H., and Levine J. Homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res 38 4 (2004) 413-416
34. Goff D.C., Bottiglieri T., Arning E., Shih V., Freudenreich O., Evins A.E., et al. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry 161 9 (2004) 1705-1708
35. Levine J., Stahl Z., Sela B.A., Gavendo S., Ruderman V., and Belmaker R.H. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 159 10 (2002) 1790-1792
36. Regland B., Johansson B.V., Grenfeldt B., Hjelmgren L.T., and Medhus M. Homocysteinemia is a common feature of schizophrenia. J Neural Transm Gen Sect 100 2 (1995) 165-169
37. Emsley R., Oosthuizen P., and van Rensburg S.J. Clinical potential of omega-3 fatty acids in the treatment of schizophrenia. CNS Drugs 17 15 (2003) 1081-1091
38. Fenton W.S., Hibbeln J., and Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47 1 (2000) 8-21
39. Godfrey P.S., Toone B.K., Carney M.W., Flynn T.G., Bottiglieri T., Laundy M., et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336 8712 (1990) 392-395
40. Abdolmaleky H.M., Smith C.L., Faraone S.V., Shafa R., Stone W., Glatt S.J., et al. Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet 127 1 (2004) 51-59
41. Bjornsson H.T., Fallin M.D., and Feinberg A.P. An integrated epigenetic and genetic approach to common human disease. Trends Genet 20 8 (2004) 350-358
42. Dennis C. Epigenetics and disease: altered states. Nature 421 6924 (2003) 686-688
43. Petronis A. Human morbid genetics revisited: relevance of epigenetics. Trends Genet 17 3 (2001) 142-146
44. Petronis A. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry 55 10 (2004) 965-970
45. Levenson J.M., and Sweatt J.D. Epigenetic mechanisms in memory formation. Nat Rev Neurosci 6 2 (2005) 108-118
46. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102 30 (2005) 10604-10609
47. Waterland R.A., and Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23 15 (2003) 5293-5300
48. Waterland R.A., and Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20 1 (2004) 63-68
49. Friso S., Choi S.W., Girelli D., Mason J.B., Dolnikowski G.G., Bagley P.J., et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A 99 8 (2002) 5606-5611
50. Friso S., and Choi S.W. Gene-nutrient interactions and DNA methylation. J Nutr 132 8 Suppl (2002) 2382S-2387S
51. Ingrosso D., Cimmino A., Perna A.F., Masella L., De Santo N.G., De Bonis M.L., et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361 9370 (2003) 1693-1699
52. Lillycrop K.A., Phillips E.S., Jackson A.A., Hanson M.A., and Burdge G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr 135 6 (2005) 1382-1386
53. Champagne F.A., and Curley J.P. How social experiences influence the brain. Curr Opin Neurobiol 15 6 (2005) 704-709
54. Petronis A., Gottesman I.I., Kan P., Kennedy J.L., Basile V.S., Paterson A.D., et al. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?. Schizophr Bull 29 1 (2003) 169-178
55. Cohen S.M., Nichols A., Wyatt R., and Pollin W. The administration of methionine to chronic schizophrenic patients: a review of ten studies. Biol Psychiatry 8 2 (1974) 209-225
56. Dong E., Agis-Balboa R.C., Simonini M.V., Grayson D.R., Costa E., and Guidotti A. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci U S A 102 35 (2005) 12578-12583
57. Tremolizzo L., Carboni G., Ruzicka W.B., Mitchell C.P., Sugaya I., Tueting P., et al. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S A 99 26 (2002) 17095-17100
58. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., and Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 57 3 (2005) 252-260
59. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 134 1 (2005) 60-66
60. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 102 26 (2005) 9341-9346
61. Fatemi S.H., Snow A.V., Stary J.M., Araghi-Niknam M., Reutiman T.J., Lee S., et al. Reelin signaling is impaired in autism. Biol Psychiatry 57 7 (2005) 777-787
62. Iwamoto K., Bundo M., Yamada K., Takao H., Iwayama-Shigeno Y., Yoshikawa T., et al. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci 25 22 (2005) 5376-5381
63. Murphy B.C., O'Reilly R.L., and Singh S.M. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia. Am J Med Genet B Neuropsychiatr Genet 133 1 (2005) 37-42
64. James S.J., Cutler P., Melnyk S., Jernigan S., Janak L., Gaylor D.W., et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80 6 (2004) 1611-1617
65. Lamb J.A., Barnby G., Bonora E., Sykes N., Bacchelli E., Blasi F., et al. Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects. J Med Genet 42 2 (2005) 132-137
66. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr 71 5 Suppl (2000) 1262S-1269S
67. Innis S.M. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 143 4 (2003) S1-S8
68. Kurlak L.O., and Stephenson T.J. Plausible explanations for effects of long chain polyunsaturated fatty acids (LCPUFA) on neonates. Arch Dis Child Fetal Neonatal Ed 80 2 (1999) F148-F154
69. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354 9177 (1999) 447-455
70. Calder P.C. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 107 1 (2004) 1-11
71. Ghosh P., Bitsanis D., Ghebremeskel K., Crawford M.A., and Poston L. Abnormal aortic fatty acid composition and small artery function in offspring of rats fed a high fat diet in pregnancy. J Physiol 533 Pt 3 (2001) 815-822
72. Clarke S.D. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 15 1 (2004) 13-18
73. Duplus E., and Forest C. Is there a single mechanism for fatty acid regulation of gene transcription?. Biochem Pharmacol 64 5-6 (2002) 893-901
74. Jump D.B. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41 1 (2004) 41-78
75. Lapillonne A., Clarke S.D., and Heird W.C. Polyunsaturated fatty acids and gene expression. Curr Opin Clin Nutr Metab Care 7 2 (2004) 151-156
76. Kitajka K., Puskas L.G., Zvara A., Hackler L., Barcelo-Coblijn G., Yeo Y.K., et al. The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci U S A 99 5 (2002) 2619-2624
77. Kitajka K., Sinclair A.J., Weisinger R.S., Weisinger H.S., Mathai M., Jayasooriya A.P., et al. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A 101 30 (2004) 10931-10936
78. Chalon S., Delion-Vancassel S., Belzung C., Guilloteau D., Leguisquet A.M., Besnard J.C., et al. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. J Nutr 128 12 (1998) 2512-2519
79. Broadhurst C.L., Cunnane S.C., and Crawford M.A. Rift Valley lake fish and shellfish provided brain-specific nutrition for early Homo. Br J Nutr 79 1 (1998) 3-21
80. Broadhurst C.L., Wang Y., Crawford M.A., Cunnane S.C., Parkington J.E., and Schmidt W.F. Brain-specific lipids from marine, lacustrine, or terrestrial food resources: potential impact on early African Homo sapiens. Comp Biochem Physiol B Biochem Mol Biol 131 4 (2002) 653-673
81. Cordain L., Watkins B.A., and Mann N.J. Fatty acid composition and energy density of foods available to African hominids. Evolutionary implications for human brain development. World Rev Nutr Diet 90 (2001) 144-161
82. Crawford M.A., Bloom M., Broadhurst C.L., Schmidt W.F., Cunnane S.C., Galli C., et al. Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain. Lipids 34 Suppl (1999) S39-S47
83. Crawford M.A., Bloom M., Cunnane S., Holmsen H., Ghebremeskel K., Parkington J., et al. Docosahexaenoic acid and cerebral evolution. World Rev Nutr Diet 88 (2001) 6-17
84. Crawford M.A. Cerebral evolution. Nutr Health 16 1 (2002) 29-34
85. Cunnane S.C., and Crawford M.A. Survival of the fattest: fat babies were the key to evolution of the large human brain. Comp Biochem Physiol A Mol Integr Physiol 136 1 (2003) 17-26
86. Gibbons A. American Association of Physical Anthropologists meeting. Humans' head start: new views of brain evolution. Science 296 5569 (2002) 835-837
87. Leonard W.R., Robertson M.L., Snodgrass J.J., and Kuzawa C.W. Metabolic correlates of hominid brain evolution. Comp Biochem Physiol A Mol Integr Physiol 136 1 (2003) 5-15
88. Burdge G.C., Jones A.E., and Wootton S.A. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men*. Br J Nutr 88 4 (2002) 355-363
89. Burdge G.C., and Wootton S.A. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 88 4 (2002) 411-420
90. Fokkema M.R., Brouwer D.A., Hasperhoven M.B., Martini I.A., and Muskiet F.A. Short-term supplementation of low-dose gamma-linolenic acid (GLA), alpha-linolenic acid (ALA), or GLA plus ALA does not augment LCP omega 3 status of Dutch vegans to an appreciable extent. Prostaglandins Leukot Essent Fatty Acids 63 5 (2000) 287-292
91. Muskiet F.A., Fokkema M.R., Schaafsma A., Boersma E.R., and Crawford M.A. Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. J Nutr 134 1 (2004) 183-186
92. Cunnane S.C., Menard C.R., Likhodii S.S., Brenna J.T., and Crawford M.A. Carbon recycling into de novo lipogenesis is a major pathway in neonatal metabolism of linoleate and alpha-linolenate. Prostaglandins Leukot Essent Fatty Acids 60 5-6 (1999) 387-392
93. Budowski P., and Crawford M.A. a-Linolenic acid as a regulator of the metabolism of arachidonic acid: dietary implications of the ratio, n-6:n-3 fatty acids. Proc Nutr Soc 44 2 (1985) 221-229
94. Simopoulos A.P. Essential fatty acids in health and chronic disease. Am J Clin Nutr 70 3 Suppl (1999) 560S-569S
95. Fiennes R.N., Sinclair A.J., and Crawford M.A. Essential fatty acid studies in primates linolenic acid requirements of capuchins. J Med Primatol 2 3 (1973) 155-169
96. Connor W.E., Neuringer M., and Reisbick S. Essentiality of omega 3 fatty acids: evidence from the primate model and implications for human nutrition. World Rev Nutr Diet 66 (1991) 118-132
97. Crawford M.A., Costeloe K., Doyle W., Leighfield M.J., Lennon E.A., and Meadows N. Potential diagnostic value of the umbilical artery as a definition of neural fatty acid status of the fetus during its growth: the umbilical artery as a diagnostic tool. Biochem Soc Trans 18 5 (1990) 761-766
98. Foreman-van Drongelen M.M., van Houwelingen A.C., Kester A.D., Hasaart T.H., Blanco C.E., and Hornstra G. Long-chain polyunsaturated fatty acids in preterm infants: status at birth and its influence on postnatal levels. J Pediatr 126 4 (1995) 611-618
99. Koletzko B., and Braun M. Arachidonic acid and early human growth: is there a relation?. Ann Nutr Metab 35 3 (1991) 128-131
100. Leaf A.A., Leighfield M.J., Costeloe K.L., and Crawford M.A. Factors affecting long-chain polyunsaturated fatty acid composition of plasma choline phosphoglycerides in preterm infants. J Pediatr Gastroenterol Nutr 14 3 (1992) 300-308
101. Crawford M.A., Golfetto I., Ghebremeskel K., Min Y., Moodley T., Poston L., et al. The potential role for arachidonic and docosahexaenoic acids in protection against some central nervous system injuries in preterm infants. Lipids 38 4 (2003) 303-315
102. Sangiovanni J.P., Parra-Cabrera S., Colditz G.A., Berkey C.S., and Dwyer J.T. Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 105 6 (2000) 1292-1298
103. Bouwstra H., Dijck-Brouwer D.A., Wildeman J.A., Tjoonk H.M., van der Heide J.C., Boersma E.R., et al. Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants. Am J Clin Nutr 78 2 (2003) 313-318
104. Bouwstra H., Dijck-Brouwer D.A., Boehm G., Boersma E.R., Muskiet F.A., and Hadders-Algra M. Long-chain polyunsaturated fatty acids and neurological developmental outcome at 18 months in healthy term infants. Acta Paediatr 94 1 (2005) 26-32
105. Sangiovanni J.P., Berkey C.S., Dwyer J.T., and Colditz G.A. Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic review. Early Hum Dev 57 3 (2000) 165-188
106. Simmer K. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2 (2000) CD000376
107. Simmer K. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2 (2000) CD000375
108. Simmer K., and Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 1 (2004) CD000375
109. Christensen O., and Christensen E. Fat consumption and schizophrenia. Acta Psychiatr Scand 78 5 (1988) 587-591
110. Horrobin D.F. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30 3 (1998) 193-208
111. Kuipers R.S., Fokkema M.R., Smit E.N., van der Meulen J., Boersma E.R., and Muskiet F.A. High contents of both docosahexaenoic and arachidonic acids in milk of women consuming fish from lake Kitangiri (Tanzania): targets for infant formulae close to our ancient diet?. Prostaglandins Leukot Essent Fatty Acids 72 4 (2005) 279-288
112. Ross B.M. Phospholipid and eicosanoid signaling disturbances in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 69 6 (2003) 407-412
113. Bell J.G., MacKinlay E.E., Dick J.R., MacDonald D.J., Boyle R.M., and Glen A.C. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids 71 4 (2004) 201-204
114. Fox H., Ross B.M., Tocher D., Horrobin D., Glen I., and St Clair D. Degradation of specific polyunsaturated fatty acids in red blood cells stored at -20 degrees C proceeds faster in patients with schizophrenia when compared with healthy controls. Prostaglandins Leukot Essent Fatty Acids 69 5 (2003) 291-297
115. Das U.N. Can perinatal supplementation of long-chain polyunsaturated fatty acids prevents schizophrenia in adult life?. Med Sci Monit 10 12 (2004) HY33-HY37
116. Klerman G.L., and Weissman M.M. Increasing rates of depression. JAMA 261 15 (1989) 2229-2235
117. Hibbeln J.R. Fish consumption and major depression. Lancet 351 9110 (1998) 1213
118. Hibbeln J.R. Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord 69 1-3 (2002) 15-29
119. Peet M. Nutrition and schizophrenia: beyond omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 70 4 (2004) 417-422
120. Peet M. International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. Br J Psychiatry 184 (2004) 404-408
121. Peet M., and Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 65 8 (2005) 1051-1059